rs141211499
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 1P and 6B. PP2BP4_ModerateBS2
The NM_205836.3(FBXO38):c.2212G>A(p.Glu738Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000465 in 1,614,140 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_205836.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBXO38 | NM_205836.3 | c.2212G>A | p.Glu738Lys | missense_variant | 15/22 | ENST00000340253.10 | NP_995308.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBXO38 | ENST00000340253.10 | c.2212G>A | p.Glu738Lys | missense_variant | 15/22 | 5 | NM_205836.3 | ENSP00000342023 | P3 | |
FBXO38 | ENST00000394370.7 | c.2212G>A | p.Glu738Lys | missense_variant | 15/22 | 1 | ENSP00000377895 | A1 | ||
FBXO38 | ENST00000513826.1 | c.1918+1805G>A | intron_variant | 1 | ENSP00000426410 | A1 | ||||
FBXO38 | ENST00000296701.10 | c.1918+1805G>A | intron_variant | 2 | ENSP00000296701 | A1 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152190Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000680 AC: 17AN: 250020Hom.: 0 AF XY: 0.0000591 AC XY: 8AN XY: 135278
GnomAD4 exome AF: 0.0000465 AC: 68AN: 1461830Hom.: 0 Cov.: 32 AF XY: 0.0000481 AC XY: 35AN XY: 727212
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152310Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74486
ClinVar
Submissions by phenotype
Distal hereditary motor neuropathy type 2 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 24, 2024 | This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 738 of the FBXO38 protein (p.Glu738Lys). This variant is present in population databases (rs141211499, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with FBXO38-related conditions. ClinVar contains an entry for this variant (Variation ID: 566193). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt FBXO38 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at